18 August 2025
18 August 2025
The drug received accelerated approval for use in patients with metabolic dysfunction-associated steatohepatitis (MASH).
Precigen’s immunotherapy will likely reduce the need for repeat surgeries in recurrent respiratory papillomatosis (RRP) patients.
The approval was based on data from two Phase III clinical trials with 1,000 participants.
The White House has blamed the Biden administration for failing to advance domestic production or fill the reserve.
The drug is now the first and only disease-modifying therapy to be approved for type 1 diabetes in the UK.
In addition to treating IgG4-RD, rilzabrutinib has been recognised internationally with orphan designations for ITP.
Anaphylm begins to dissolve upon contact, eliminating the need for water or swallowing during administration.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
